» Articles » PMID: 35898971

Lipoic Acid Restores Binding of Zinc Ions to Human Serum Albumin

Overview
Journal Front Chem
Specialty Chemistry
Date 2022 Jul 28
PMID 35898971
Authors
Affiliations
Soon will be listed here.
Abstract

Human serum albumin (HSA) is the main zinc(II) carrier in blood plasma. The HSA site with the strongest affinity for zinc(II), multi-metal binding site A, is disrupted by the presence of fatty acids (FAs). Therefore, the FA concentration in the blood influences zinc distribution, which may affect both normal physiological processes and a range of diseases. Based on the current knowledge of HSA's structure and its coordination chemistry with zinc(II), we investigated zinc interactions and the effect of various FAs, including lipoic acid (LA), on the protein structure, stability, and zinc(II) binding. We combined NMR experiments and isothermal titration calorimetry to examine zinc(II) binding to HSA at a sub-atomic level in a quantitative manner as well as the effect of FAs. Free HSA results indicate the existence of one high-affinity zinc(II) binding site and multiple low-affinity sites. Upon the binding of FAs to HSA, we observed a range of behaviors in terms of zinc(II) affinity, depending on the type of FA. With FAs that disrupt zinc binding, the addition of LA restores HSA's affinity for zinc ions to the levels seen with free defatted HSA, indicating the possible mechanism of LA, which is effective in the treatment of diabetes and cardiovascular diseases.

Citing Articles

Unraveling the versatility of human serum albumin - A comprehensive review of its biological significance and therapeutic potential.

Ashraf S, Qaiser H, Tariq S, Khalid A, Makeen H, Alhazmi H Curr Res Struct Biol. 2023; 6:100114.

PMID: 38111902 PMC: 10726258. DOI: 10.1016/j.crstbi.2023.100114.


Food Antioxidants and Their Interaction with Human Proteins.

Nedic O, Penezic A, Minic S, Radomirovic M, Nikolic M, Cirkovic Velickovic T Antioxidants (Basel). 2023; 12(4).

PMID: 37107190 PMC: 10135064. DOI: 10.3390/antiox12040815.


Metformin Prevents or Delays the Development and Progression of Osteoarthritis: New Insight and Mechanism of Action.

He M, Lu B, Opoku M, Zhang L, Xie W, Jin H Cells. 2022; 11(19).

PMID: 36230974 PMC: 9563728. DOI: 10.3390/cells11193012.


Strategies for Therapeutic Amelioration of Aberrant Plasma Zn Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects.

Regan-Smith S, Fritzen R, Hierons S, Ajjan R, Blindauer C, Stewart A Int J Mol Sci. 2022; 23(18).

PMID: 36142215 PMC: 9499645. DOI: 10.3390/ijms231810302.

References
1.
Smith K, Failla M, Cousins R . Identification of albumin as the plasma carrier for zinc absorption by perfused rat intestine. Biochem J. 1979; 184(3):627-33. PMC: 1161847. DOI: 10.1042/bj1840627. View

2.
Petitpas I, Grune T, Bhattacharya A, Curry S . Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol. 2001; 314(5):955-60. DOI: 10.1006/jmbi.2000.5208. View

3.
Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K . Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999; 12(6):439-46. DOI: 10.1093/protein/12.6.439. View

4.
Hershfinkel M . The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease. Int J Mol Sci. 2018; 19(2). PMC: 5855661. DOI: 10.3390/ijms19020439. View

5.
Lu J, Stewart A, Sleep D, Sadler P, Pinheiro T, Blindauer C . A molecular mechanism for modulating plasma Zn speciation by fatty acids. J Am Chem Soc. 2012; 134(3):1454-7. PMC: 3285120. DOI: 10.1021/ja210496n. View